Zyga enrolls first patients in sacroiliac joint fusion trial: 4 points

Minnetonka, Minn.-based Zyga Technology enrolled the first four patients in its EVoluSIon Clinical Study.

Advertisement

Here are four points:

 

1. The clinical study is evaluating long-term fusion and pain reduction in patients receiving SImmetry Sacroiliac Joint Fusion.

 

2. The 40-site study will involve 250 patients.

 

3. Antoine G. Tohmeh, MD, performed the clinical study’s first procedures at Deaconess Hospital in Spokane, Wash.

 

4. Zyga will present at the 2016 International Society for the Advancement of Spine Surgery meeting in Las Vegas in April.

 

“Minimally invasive SI joint fusion procedures are rapidly gaining acceptance within the medical community, but it is important that the technology gives patients the best opportunity for long-term relief,” said Dr. Tohmeh.

 

More articles on devices:
InVivo Therapeutics adds UVA Health System as INSPIRE study site: 4 takeaways
Anika Therapeutics names CMO, COO: 4 points
CareCredit, DePuy Synthes Mitek Sports Medicine form agreement — 3 highlights

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.